Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION CONTAINING OSMOTIN PEPTIDE AS ACTIVE INGREDIENT FOR PREVENTION, IMPROVEMENT OR TREATMENT OF DIABETES
Document Type and Number:
WIPO Patent Application WO/2016/208908
Kind Code:
A1
Abstract:
The present invention relates to a composition containing osmotin peptide as an active ingredient for the prevention, improvement or treatment of diabetes. Specifically, the present invention provides a composition containing osmotin peptide as an active ingredient for the prevention, improvement or treatment of diabetes by having confirmed that blood glucose content markedly decreased in a model mouse which had obesity induced therein, and then was treated with osmotin peptide.

Inventors:
KIM MYEONG OK (KR)
Application Number:
PCT/KR2016/006404
Publication Date:
December 29, 2016
Filing Date:
June 16, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
INDUSTRY-ACADEMIC COOP FOUND GYEONGSANG NAT UNIV (KR)
International Classes:
A61K38/08; C07K7/06
Foreign References:
KR101308232B12013-11-06
KR20150064423A2015-06-11
Other References:
MIELE, MARCO ET AL.: "Structural and Functional Similarities between Osmotin from Nicotiana Tabacum Seeds and Human Adiponectin", PLOS ONE, vol. 6, no. 2, 2 February 2011 (2011-02-02), pages 1 - 11, XP055310265
TRIVEDI, VANDIT R. ET AL.: "Osmotin: A New Adiponectin Agonist, in Type-II Diabetes and Obesity", INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES REVIEW AND RESEARCH, vol. 16, no. 1, 2012, pages 70 - 74, XP055337954
NARASIMHAN, MEENA L. ET AL.: "Osmotin is a Homolog of Mammalian Adiponectin and Controls Apoptosis in Yeast through a Homolog of Mammalian Adiponect in Receptor", MOLECULAR CELL, vol. 17, no. 2, 21 January 2005 (2005-01-21), pages 171 - 180, XP055338816
Attorney, Agent or Firm:
CHOI, Kyu Whan (KR)
최규환 (KR)
Download PDF: